Stockscreener 앱 받기
5.60
3.95%
-0.23
시간 외 거래:
5.63
0.03
+0.54%
전일 마감가:
$5.83
열려 있는:
$5.89
하루 거래량:
196.45K
Relative Volume:
1.01
시가총액:
$117.18M
수익:
-
순이익/손실:
$-14.88M
주가수익비율:
-5.7143
EPS:
-0.98
순현금흐름:
$-10.29M
1주 성능:
-8.05%
1개월 성능:
-4.27%
6개월 성능:
+5.26%
1년 성능:
-0.18%
1일 변동 폭
$5.5667
$6.01
1주일 범위
$5.5667
$6.44
52주 변동 폭
$4.65
$8.29
Coya Therapeutics Inc Stock (COYA) Company Profile
명칭
Coya Therapeutics Inc
전화
650.739.3939
주소
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
COYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
5.60 | 121.99M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.52 | 115.43B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
749.79 | 78.44B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
862.05 | 52.42B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.10 | 51.68B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
198.46 | 42.80B | 447.02M | -1.18B | -906.14M | -6.1812 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-09 | 개시 | Lake Street | Buy |
| 2024-12-04 | 개시 | D. Boral Capital | Buy |
Coya Therapeutics Inc 주식(COYA)의 최신 뉴스
Coya Therapeutics Receives $4.2M Milestone Payment - TipRanks
Coya Therapeutics Receives Milestone Payment for ALS Trial - TradingView — Track All Markets
Coya Therapeutics, Inc. (NASDAQ:COYA) Receives $16.00 Average Price Target from Brokerages - Defense World
Coya Therapeutics, Inc. (NASDAQ:COYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Responsive Playbooks and the COYA Inflection - news.stocktradersdaily.com
H.C. Wainwright reiterates Buy rating on Coya Therapeutics stock By Investing.com - Investing.com Canada
Buy Rating for Coya: Phase 2 Trial Initiation and Financial Milestones Boost Prospects - TipRanks
Coya Therapeutics Announces Patients Have Been Dosed in the ALSTARS Trial of COYA 302 for the Treatment of ALS - BioSpace
Coya Therapeutics, Inc.: Promising Advancements in ALS and FTD Treatment with COYA-302 - TipRanks
D. Boral Capital Maintains Coya Therapeutics (COYA) Buy Recommendation - Nasdaq
Coya Therapeutics Announces Patients Have Been Dosed in the Alstars Trial of Coya 302 for the Treatment of Als - marketscreener.com
Coya Therapeutics' (COYA) "Buy" Rating Reaffirmed at D. Boral Capital - MarketBeat
Eisai Still Confident in Anti-Tau Asset as J&J Becomes Latest Victim in Spiraling Space - BioSpace
Coya Therapeutics (COYA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Understanding the Setup: (COYA) and Scalable Risk - news.stocktradersdaily.com
Investor Presentation (12/01/2025 00: 00 - marketscreener.com
Highs Report: Is Coya Therapeutics Inc. stock a top momentum play2025 Growth vs Value & Advanced Swing Trade Entry Plans - BỘ NỘI VỤ
HC Wainwright Lifts Earnings Estimates for Coya Therapeutics - MarketBeat
Coya Therapeutics to Participate in Upcoming Investor Relations and Clinical Trials Conferences - BioSpace
Form 424B5Prospectus [Rule 424(b)(5)] - ADVFN
H.C. Wainwright Maintains Coya Therapeutics(COYA.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛
H.C. Wainwright reaffirms Buy rating on Coya Therapeutics stock at $18 target - Investing.com Canada
Coya Therapeutics: Strong Financial Position and Upcoming Catalysts Support Buy Rating - TipRanks
What drives Coya Therapeutics Inc stock pricePortfolio Risk Assessment & Outstanding Growth Portfolio - earlytimes.in
D. Boral Capital Initiates Coverage of Coya Therapeutics (COYA) with Buy Recommendation - MSN
Is Coya Therapeutics Inc. stock a buy before product launchesJuly 2025 Outlook & Short-Term Trading Alerts - newser.com
Is Coya Therapeutics Inc. stock cheap at current valuationJuly 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com
The Technical Signals Behind (COYA) That Institutions Follow - news.stocktradersdaily.com
Can Coya Therapeutics Inc. stock weather global recessionBull Run & Risk Controlled Stock Pick Alerts - newser.com
How Coya Therapeutics Inc. stock performs in interest rate cycles2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - newser.com
Why Coya Therapeutics Inc. stock could benefit from AI revolutionTrade Risk Report & Fast Exit/Entry Strategy Plans - newser.com
Price momentum metrics for Coya Therapeutics Inc. explained2025 Biggest Moves & Daily Risk Controlled Trade Plans - newser.com
Coya Therapeutics, Inc. (NASDAQ:COYA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Is Coya Therapeutics Inc. still worth holding after the dipMarket Trend Review & Growth Focused Stock Reports - newser.com
What to do if you’re stuck in Coya Therapeutics Inc.2025 Historical Comparison & Smart Investment Allocation Tips - newser.com
Is Coya Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Closing Moves & AI Powered Buy/Sell Recommendations - newser.com
Coya Therapeutics (NASDAQ: COYA) starts Phase 2 COYA 302 ALS study in 120 patients - Stock Titan
What analyst consensus says on Coya Therapeutics Inc. stockCPI Data & Weekly Breakout Watchlists - newser.com
Coya Therapeutics (NASDAQ:COYA) Receives "Buy" Rating from Chardan Capital - MarketBeat
Coya Therapeutics Inc (COYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.18%
0.62%
자본화:
|
볼륨(24시간):